IVORC
  • Register
  • Login

Medical hypothesis, discovery & innovation in optometry

  1. Home
  2. Archives
  3. Vol. 3 No. 2 (2022): Summer 2022
  4. Articles

About the Journal

Editorial Team

Privacy Statement

Contact

A brief review of Valsalva retinopathy

  • Petros Asteris
  • Dimitrios Kalogeropoulos
  • George Moussa
  • Ioannis Iraklis Vitos
  • Aikaterini Christodoulou
  • Chris Kalogeropoulos

Medical hypothesis, discovery & innovation in optometry, Vol. 3 No. 2 (2022), 29 October 2022 , Page 42-47
https://doi.org/10.51329/mehdioptometry149 Published 28 October 2022

  • View Article
  • Download
  • Share

Abstract

Background: Valsalva retinopathy is a specific type of retinopathy that appears following an acute rise in intrathoracic or intra-abdominal pressure. This review focuses on current literature and future directions for the diagnosis and management of Valsalva retinopathy.
Methods: In this brief review, the literature was searched to provide an extensive general and updated description of Valsalva retinopathy, focusing on its management and prognosis. Selected articles are summarized to present the etiology, general pathology, pathophysiology, symptoms, signs, diagnosis, differential diagnosis, treatment, and prognosis of Valsalva retinopathy.
Results: The main symptom of Valsalva retinopathy is loss of visual acuity following exertion. This is caused by the rupture of small superficial vessels in the macula and perimacular areas, leading to extravasation of blood. No link between age, sex, or race has been found, although fundus vessel abnormalities pose some predisposition to the disease. During fundoscopy, Valsalva retinopathy appears most frequently as well-defined preretinal hemorrhages confined to the sub-internal limiting membrane (ILM) or subhyaloid space. If ILM rupture occurs, hyaloid hemorrhage can appear. Diagnosis is based on the patient’s medical history and a standard examination. Usually, only observation of the patient is required, with the hemorrhage resolving within weeks to months. In cases of large premacular hemorrhage or large sub-ILM/subhyaloid hemorrhage, vitrectomy or Nd:YAG krypton laser membranotomy can be performed.
Conclusions: Of all the aspects of Valsalva retinopathy that might trouble the physician, the most challenging features are differential diagnosis and the choice of optimal treatment. Therapeutic strategies for Valsalva retinopathy can be either conservative or based on Nd:YAG laser membranotomy and/or vitrectomy. All methods seem to have good outcomes. However, physicians should not be afraid of advancing beyond conservative therapy, especially in the event of persistent premacular hemorrhage, which could lead to permanent retinal damage if valuable time is lost, even after vitrectomy.
Keywords:
  • Valsalva maneuver
  • retinopathy
  • retina
  • optical coherence tomography
  • Nd-YAG laser
  • Neodymium-Doped Yttrium Aluminum Garnet laser
  • Full Text PDF
  • Abstract Viewed: 0 times
  • Full Text PDF Downloaded: 0 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Open Journal Systems
Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
© Copyright 2020-2025, CC BY-NC 4.0. All Rights Reserved.

Medical Hypothesis, Discovery & Innovation in Optometry
ISSN 2693-8391